Loading…
avatar for Dr. Pamela Reilly Contag

Dr. Pamela Reilly Contag

CEO of Cygnet Biofuels

Pamela R. Contag, Ph.D., is currently the CEO of Cygnet Biofuels. Pam founded four venture-backed start-up companies; Xenogen Corporation was listed as one of the “Top 25 Young Businesses” by Fortune Small Business and in both 2001 and 2003 received the R&D 100 award for achievements in Physics. Xenogen Corp. completed a public offering in 2004 and was subsequently acquired by Caliper Life Sciences; Cobalt Technologies, was named multiple times as a Top 20 Company in Cleantech, as is now in product demonstration; Cygnet Biofuels, is a company that consults and develops platforms in biomass and biofuels; and ConcentRx, is a novel therapeutic for oncology indications. Pam was named one of the “Top 25 Women in Small Business” by Fortune magazine. In 2011, Pam joined the Founding Board of the Startup America Partnership an organization envisioned by the Case and Kauffman Foundation and The White House to identify, encourage and celebrate all entrepreneurs.

Pam has held various consulting and board positions, public, private and not-for-profit. Those positions include a consulting Professorship at Stanford School of Medicine in the Department of Pediatrics (1999-present), the Dean’s Advisory Board of the Johns Hopkins Bloomberg School of Public Health (1999-2005). Pam was a Director of Xenogen Corporation (Nasdaq) (1995-2005) and was CEO and Chairman of Cobalt Technologies (2005-2008) and a Delcath (Nasdaq) Board Member (2008-2011). She also joined in 2009 the DOE Biomass technology Advisory Committee and two nonprofit boards, Springboard Enterprises, an accelerator of women entrepreneurs and the VTT-MSI Center for Bioengineering. In 2010 Pam joined the Merrick Engineering Consultancy specializing in the energy field.

With more than 25 years of microbiology research experience, Pam is widely published in the field of Microbiology and Optical imaging and has over 36 patents and patent applications. Dr. Contag received her Ph.D. in Microbiology at the University of Minnesota Medical School in 1989 and completed her Postdoctoral Training at Stanford University School of Medicine in 1993 specializing in “Host/Pathogen
Interactions”.